Healthstream (HSTM) Receivables (2010 - 2026)

Healthstream (HSTM) has 17 years of Receivables data on file, last reported at $43.4 million in Q1 2026.

• On a quarterly basis, Receivables rose 20.39% year-over-year to $43.4 million in Q1 2026; TTM through Mar 2026 was $43.4 million, a 20.39% increase from a year earlier, with the FY2025 full-year figure at $39.0 million, up 10.41% from the prior year.
• Receivables for Q1 2026 stood at $43.4 million, up from $39.0 million in the prior quarter.
• Over the last five years, Receivables for HSTM reached as high as $47.3 million in Q1 2023 and fell as low as $31.5 million in Q2 2025.
• Historically, Receivables has averaged $37.9 million across 5 years, with a median of $36.2 million in 2024.
• Across the five-year window, Receivables gained 22.31% in 2022 and declined 18.08% in 2025, its largest moves.
• Year by year, Receivables stood at $42.7 million in 2022, then slipped by 9.98% to $38.4 million in 2023, then retreated by 8.13% to $35.3 million in 2024, then rose by 10.41% to $39.0 million in 2025, then increased by 11.4% to $43.4 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $43.4 million in Q1 2026, $39.0 million in Q4 2025, and $33.7 million in Q3 2025.